JP2021528447A5 - - Google Patents
Info
- Publication number
- JP2021528447A5 JP2021528447A5 JP2020571700A JP2020571700A JP2021528447A5 JP 2021528447 A5 JP2021528447 A5 JP 2021528447A5 JP 2020571700 A JP2020571700 A JP 2020571700A JP 2020571700 A JP2020571700 A JP 2020571700A JP 2021528447 A5 JP2021528447 A5 JP 2021528447A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oxadiazole
- azabicyclo
- octan
- diazaspiro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023158190A JP2023164721A (ja) | 2018-06-22 | 2023-09-22 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
| JP2025174614A JP2026002915A (ja) | 2018-06-22 | 2025-10-16 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1810245.9A GB201810245D0 (en) | 2018-06-22 | 2018-06-22 | Pharmaceutical compounds |
| GB1810245.9 | 2018-06-22 | ||
| PCT/GB2019/051778 WO2019243850A1 (en) | 2018-06-22 | 2019-06-24 | Oxadiazoles as agonists of the muscarinic m1 and/or m4 receptor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023158190A Division JP2023164721A (ja) | 2018-06-22 | 2023-09-22 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021528447A JP2021528447A (ja) | 2021-10-21 |
| JP2021528447A5 true JP2021528447A5 (enExample) | 2022-07-01 |
| JP7389762B2 JP7389762B2 (ja) | 2023-11-30 |
Family
ID=63042556
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571700A Active JP7389762B2 (ja) | 2018-06-22 | 2019-06-24 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
| JP2023158190A Withdrawn JP2023164721A (ja) | 2018-06-22 | 2023-09-22 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
| JP2025174614A Pending JP2026002915A (ja) | 2018-06-22 | 2025-10-16 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023158190A Withdrawn JP2023164721A (ja) | 2018-06-22 | 2023-09-22 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
| JP2025174614A Pending JP2026002915A (ja) | 2018-06-22 | 2025-10-16 | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10858352B2 (enExample) |
| EP (1) | EP3810607A1 (enExample) |
| JP (3) | JP7389762B2 (enExample) |
| KR (1) | KR102833588B1 (enExample) |
| CN (2) | CN119039284A (enExample) |
| AU (1) | AU2019289216B2 (enExample) |
| BR (1) | BR112020026437A2 (enExample) |
| CA (1) | CA3104085A1 (enExample) |
| GB (1) | GB201810245D0 (enExample) |
| MX (1) | MX2020014156A (enExample) |
| SG (1) | SG11202012570TA (enExample) |
| TW (1) | TWI872024B (enExample) |
| WO (1) | WO2019243850A1 (enExample) |
| ZA (1) | ZA202007986B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2780015B1 (en) | 2011-11-18 | 2017-01-04 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201810245D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) * | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| WO2021070090A1 (en) * | 2019-10-09 | 2021-04-15 | Novartis Ag | 2-azaspiro[3.4]octane derivatives as m4 agonists |
| CN119390705A (zh) | 2019-10-09 | 2025-02-07 | 诺华股份有限公司 | 作为m4激动剂的5-氧杂-2-氮杂螺[3.4]辛烷衍生物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999032486A1 (en) | 1997-12-23 | 1999-07-01 | Alcon Laboratories, Inc. | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions |
| US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| AU2006330866A1 (en) | 2005-12-22 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| KR20080098070A (ko) | 2006-02-22 | 2008-11-06 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 |
| AU2007284548A1 (en) | 2006-08-15 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| WO2008117229A1 (en) * | 2007-03-23 | 2008-10-02 | Ranbaxy Laboratories Limited | Muscarinic receptor antagonists |
| EP2616074A1 (en) * | 2010-09-17 | 2013-07-24 | Array Biopharma, Inc. | Piperidinyl-substituted lactams as gpr119 modulators |
| CN107098899B (zh) * | 2012-09-18 | 2019-09-06 | 赫普泰雅治疗有限公司 | 作为毒蕈碱的m1受体激动剂的二环氮杂化合物 |
| JP6478923B2 (ja) * | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート |
| SG11201606269WA (en) * | 2014-02-06 | 2016-09-29 | Heptares Therapeutics Ltd | Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists |
| GB201404922D0 (en) * | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513742D0 (en) * | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201513743D0 (en) * | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201617454D0 (en) * | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810245D0 (en) * | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
-
2018
- 2018-06-22 GB GBGB1810245.9A patent/GB201810245D0/en not_active Ceased
-
2019
- 2019-06-24 US US16/450,279 patent/US10858352B2/en active Active
- 2019-06-24 WO PCT/GB2019/051778 patent/WO2019243850A1/en not_active Ceased
- 2019-06-24 JP JP2020571700A patent/JP7389762B2/ja active Active
- 2019-06-24 KR KR1020217001748A patent/KR102833588B1/ko active Active
- 2019-06-24 CN CN202410873092.8A patent/CN119039284A/zh active Pending
- 2019-06-24 BR BR112020026437-7A patent/BR112020026437A2/pt unknown
- 2019-06-24 EP EP19734158.9A patent/EP3810607A1/en active Pending
- 2019-06-24 MX MX2020014156A patent/MX2020014156A/es unknown
- 2019-06-24 CN CN201980054880.1A patent/CN112585135B/zh active Active
- 2019-06-24 CA CA3104085A patent/CA3104085A1/en active Pending
- 2019-06-24 TW TW108122031A patent/TWI872024B/zh active
- 2019-06-24 AU AU2019289216A patent/AU2019289216B2/en active Active
- 2019-06-24 SG SG11202012570TA patent/SG11202012570TA/en unknown
-
2020
- 2020-10-13 US US17/069,070 patent/US11319312B2/en active Active
- 2020-12-21 ZA ZA2020/07986A patent/ZA202007986B/en unknown
-
2023
- 2023-09-22 JP JP2023158190A patent/JP2023164721A/ja not_active Withdrawn
-
2025
- 2025-10-16 JP JP2025174614A patent/JP2026002915A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021528447A5 (enExample) | ||
| JP6660502B2 (ja) | ムスカリン受容体アゴニスト | |
| JP7389762B2 (ja) | ムスカリンｍ１および／またはｍ４受容体のアゴニストとしてのオキサジアゾール | |
| JP2021528446A5 (enExample) | ||
| DK2536730T3 (en) | Pyrrolopyrimidinforbindelser as CDK4 / 6 inhibitors | |
| US7538132B2 (en) | Isoxazolo derivatives | |
| JP5512268B2 (ja) | ５ｈｔ３モジュレーターとしての２−アミノベンゾオキサゾールカルボキサミド | |
| RU2450003C2 (ru) | Индазолы, бензотиазолы, бензоизотиазолы, бензоизоксазолы, пиразолопиридины, изотиазолопиридины, их получение и их применение | |
| AU2009260469B2 (en) | 5-HT3 receptor modulators, methods of making, and use thereof | |
| US20200308172A1 (en) | Substituted indole compounds useful as tlr inhibitors | |
| JP2018522034A5 (enExample) | ||
| JP2020523396A5 (enExample) | ||
| RU2020100930A (ru) | Фармацевтические соединения | |
| JP2015513552A5 (enExample) | ||
| JP2017531672A5 (enExample) | ||
| US8198296B2 (en) | Sub-type selective azabicycloalkane derivatives | |
| JP2009512677A (ja) | ホスホジエステラーゼタイプｉｖ阻害剤の組成物 | |
| CA2626612A1 (en) | Pharmaceutical compositions of muscarinic receptor antagonists | |
| WO2008112734A1 (en) | Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders | |
| JP2022508523A5 (enExample) | ||
| RU2020141712A (ru) | Оксадиазолы в качестве агонистов мускаринового рецептора m1 и/или m4 | |
| JP2009263234A (ja) | ホスホジエステラーゼタイプｉｖ阻害剤の組成物 | |
| HK40026802A (en) | Muscarinic receptor agonists | |
| NZ760749B2 (en) | Bicyclic ketone compounds and methods of use thereof | |
| NZ757607A (en) | Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors |